Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/48796| Title: | Serum digoxin concentrations : clinical signals |
| Authors: | Vella, John Wirth, Francesca Serracino-Inglott, Anthony Azzopardi, Lilian M. |
| Keywords: | Digoxin Drug monitoring -- Research -- Malta Cardiotonic agents Heart failure -- Chemotherapy Atrial fibrillation --Treatment |
| Issue Date: | 2017-09 |
| Publisher: | University of Malta. Department of Pharmacy |
| Citation: | Vella, J., Wirth, F., Serracino-Inglott, A., & Azzopardi, L. M. (2017, September). Serum digoxin concentrations: clinical signals. Poster session presented at the 77th FIP Annual Conference, Seoul, Republic of Korea. |
| Abstract: | A poster presentation regarding serum digoxin concentrations. Introduction: Digoxin, as a treatment option in cardiology, is limited by its narrow therapeutic index. • Current European Society of Cardiology (ESC) guidelines provide a Class 1 Level of Evidence B recommendation for digoxin in atrial fibrillation, and classify it as a treatment of uncertain benefit in heart failure. • Clinical guidelines recommend targeting a serum digoxin concentration (SDC) between 0.5 and 0.9 ng/ml, or <1.0 ng/ml. Aims: • To determine the number of patients on digoxin in Malta • To analyse SDCs recorded at Mater Dei Hospital (MDH) • To determine adherence to the clinically recommended target SDC • To assess queries concerning digoxin processed by the Drug Information Unit (DIU) at MDH |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/48796 |
| Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Serum_digoxin_concentrations_clinical_signals_2017.pdf | 814.01 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.